Medinova Diagnostic Services Limited has officially completed its merger with Vijaya Diagnostic Centre Limited, marking a notable consolidation in India’s healthcare diagnostics sector. The merger became effective on November 4, 2025, after both companies filed the National Company Law Tribunal (NCLT)-approved scheme of amalgamation with the Registrar of Companies in Hyderabad.
Key Merger Details
| Aspect | Details |
| Effective Date | November 4, 2025 |
| Appointed Date | April 1, 2024 |
| Share Exchange Ratio | 1 equity share of Vijaya Diagnostic Centre for every 22 equity shares of Medinova Diagnostic Services |
| Record Date | November 25, 2025 |
Under the approved scheme, Medinova Diagnostic Services Limited has been dissolved automatically, eliminating the need for separate winding-up proceedings. Following the merger, all director, key managerial, and statutory auditor positions at Medinova have been vacated with effect from November 4, 2025.
Shareholder Impact
Shareholders of Medinova Diagnostic Services who are eligible as of the record date, November 25, 2025, will receive Vijaya Diagnostic Centre shares based on the agreed 1:22 exchange ratio.
Financial Performance Prior to Merger
In its final reported financial results before the merger, Medinova Diagnostic Services posted steady performance during Q2 FY2026:
| Particulars | Q2 FY2026 (₹ in Lakhs) | H1 FY2026 (₹ in Lakhs) |
| Revenue from Operations | 188.60 | 396.43 |
| Profit Before Tax | 39.73 | 87.74 |
| Net Profit | 23.76 | 59.39 |
The merger strengthens Vijaya Diagnostic Centre’s market presence and consolidates its position within the diagnostics industry, enhancing operational reach and efficiency.
Summary:
Medinova Diagnostic Services Limited has merged with Vijaya Diagnostic Centre Limited, effective November 4, 2025, with an appointed date of April 1, 2024. Under the merger scheme, Medinova shareholders will receive Vijaya shares in a 1:22 ratio, with the record date set for November 25, 2025. Medinova has been dissolved post-merger, and its leadership positions vacated.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing